Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT
Lakewood-Amedex Biotherapeutics Inc. Common StockUS flagNASDAQ Global Market
2.44
USD
-0.30
- -
1.14MMarket Cap

Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) Stock Split History

Learn about Lakewood-Amedex Biotherapeutics Inc. Common Stock's most recent 1-for-10 basis stock split on June 22, 2026. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Lakewood-Amedex Biotherapeutics Inc. Common Stock's most recent stock split

Split Date: 2026-06-22
Split Ratio: 1:10
Price Before Split: $0.36
Price After Split: $0.04

Developer API

Get LABT split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/LABT

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 10.00 times fewer shares (a 1:10 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Lakewood-Amedex Biotherapeutics Inc. Common Stock's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2026-06-221:10Yes$0.36$0.04

About Lakewood-Amedex Biotherapeutics Inc. Common Stock

Company overview and industry information

Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) operates in the Biotechnology industry. The recent 1-for-10 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Lakewood-Amedex Biotherapeutics Inc. Common Stock Summary

Last updated: 7/7/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.